Daryl Cottrell is an Endocrinology/Metabolic physician affiliated with Riverside Methodist Hospital. OpenAlex indexes 17 publications with 349 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 Thomas Ln
Ste 2c
Columbus, OH 432143902
Telephone
614-566-5456Registry record last updated 22 Dec 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
56.7%l-Thyroxine50%Levothyroxine Sodium71%Synthroid29%Part D<11 patientsl-Triiodothyronine6.7%Liothyronine Sodium100%Part D<11 patientsMetabolism & gastrointestinal
25.8%Insulin Analog13.5%Humalog Kwikpen U-10054%Tresiba Flextouch U-10046%Part D<11 patientsSGLT2 inhibitor6.2%Jardiance100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
10.7%Androgen10.7%Testosterone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1991–2001 per NIH RePORTER. The latest:
- METABOLIC EFFECT OF PANCREAS TRANSPLANTATION IN TYPE I DIABETIC RECIPIENTS
Ohio State University
FY2001$193,916M01RR000034 - METABOLIC EFFECT OF PANCREAS TRANSPLANTATION IN TYPE I DIABETIC RECIPIENTS
Ohio State University
FY2000$48,578M01RR000034 - METABOLIC EFFECT OF PANCREAS TRANSPLANTATION IN TYPE I DIABETIC RECIPIENTS
Ohio State University
FY2000M01RR000034
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <scp>Sodium‐glucose cotransporter‐2</scp> inhibitor prescribing practices
Diabetes Obesity and Metabolism
2022 - Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome
Current Opinion in Cardiology
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Gary Ansel, MD
Riverside Methodist Hospital
Gary Reid, MD
Riverside Methodist Hospital
Nagesh Chopra, MD
Riverside Methodist Hospital
Jacqueline Nicholas, MD
Riverside Methodist Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”